Biocontrol Technologies advances its leadership in research with a new project approved by the CDTI.

Biocontrol Technologies continues to solidify its position as a leader in research and development in the field of biotechnology. In 2023, the Centre for Technological Development and Innovation (CDTI) approved the research project focused on finding biological solutions for agriculture, marking a milestone set to become a benchmark in the sector.

This project, presented under the name “New Developments and Applications of the Active Substance Trichoderma asperellum Strain T34”, has received approval from the Board of Directors of the CDTI.

It focuses on exploring new applications and developments of the active substance Trichoderma asperellumstrain T34, renowned for its beneficial properties in various fields. The approval of this project signifies a significant endorsement of Biocontrol Technologies‘ efforts to promote innovative and sustainable solutions that contribute to human well-being and environmental care.

Additionally, this achievement underscores Biocontrol Technologies ’ dedication to excellence in research and development, along with its capability to forge strategic partnerships with esteemed entities like the CDTI.

“The approval of this project by the CDTIvalidates our focus on cutting-edge research and motivates us to keep innovating to deliver solutions that benefit agriculture and society,” remarked Eduard Fernando, General Director of Biocontrol Technologies.

It’s noteworthy that Biocontrol Technologies boasts a robust research history, with over 20 years in the market, and is dedicated to developing microorganism-based technologies in plant biotechnology.

Its dedication to quality and sustainability has established it as a frontrunner in the sector, and the approval of this project marks another stride forward on its path to success.